NASDAQ:XLRN - Acceleron Pharma Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $42.46 +0.69 (+1.65 %) (As of 02/18/2019 04:00 PM ET)Previous Close$41.77Today's Range$41.36 - $42.6952-Week Range$32.53 - $59.59Volume504,851 shsAverage Volume613,991 shsMarket Capitalization$1.96 billionP/E Ratio-15.84Dividend YieldN/ABeta1.38 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Acceleron Pharma (NASDAQ:XLRN) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.10 Wall Street analysts have issued ratings and price targets for Acceleron Pharma in the last 12 months. Their average twelve-month price target is $56.20, suggesting that the stock has a possible upside of 32.36%. The high price target for XLRN is $75.00 and the low price target for XLRN is $33.00. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.702.702.642.55Ratings Breakdown: 0 Sell Rating(s)3 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)3 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)5 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $56.20$56.20$56.30$51.50Price Target Upside: 32.36% upside6.18% upside8.37% upside17.98% upsideAcceleron Pharma (NASDAQ:XLRN) Consensus Price Target History Acceleron Pharma (NASDAQ:XLRN) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails12/3/2018HC WainwrightReiterated RatingBuy$72.00Low9/17/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$52.00 ➝ $75.00High9/10/2018Morgan StanleyInitiated CoverageEqual Weight ➝ Equal Weight$55.00Medium7/12/2018Royal Bank of CanadaReiterated RatingHold$48.00Medium7/10/2018UBS GroupBoost Price TargetBuy$62.00High6/29/2018Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$55.00 ➝ $60.00High6/29/2018Goldman Sachs GroupUpgradeSell ➝ Neutral$21.00 ➝ $40.00High3/1/2018CitigroupBoost Price TargetBuy ➝ Positive$44.00 ➝ $63.00High2/28/2018BarclaysBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $54.00High2/26/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$33.00High1/8/2018OppenheimerReiterated RatingHoldMedium6/14/2017InstinetReiterated RatingBuy$58.00Low6/13/2017FBR & CoSet Price TargetBuy$63.00High6/13/2017CIBCDowngradeOutperform ➝ Market PerformLow5/1/2017JMP SecuritiesReiterated RatingOutperform$39.00Low3/1/2017NomuraInitiated CoverageBuyN/A(Data available from 2/18/2017 forward) This page was last updated on 2/18/2019 by MarketBeat.com StaffFeatured Article: How are institutional investors different from individual investors?